Form 4: GoodRx Holdings Officer Douglas Joseph Hirsch Reports Stock Transactions

Douglas Joseph Hirsch, Chief Mission Officer at GoodRx Holdings, reports the vesting and conversion of restricted stock units and subsequent transactions involving Class A and Class B common stock.

Summary

• Douglas Joseph Hirsch, Chief Mission Officer of GoodRx Holdings, filed a Form 4 detailing changes in beneficial ownership.
• On September 1, 2024, Hirsch converted 256,595 restricted stock units into Class B common stock, which were then converted into Class A common stock.
• Also on September 1, 2024, 130,043 Class B common stock were disposed of at a price of $7.9.
• Additionally, 126,552 Class B common stock were converted to Class A common stock.
• Following these transactions, Hirsch directly owns 126,552 shares of Class A Common Stock.
• Hirsch also indirectly owns 2,632,721 shares of Class A Common Stock through the DH 2024 GRAT and 2,632,721 shares through the CH 2024 GRAT.
• He also directly owns 256,595 derivative securities (Class B Common Stock) and 126,552 Class B Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company officer. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the officer's holdings.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates